Injective vs Venom — how do they compare? Injective trades at Rp92,735 (market cap Rp9,29T, Rp1,82T 24h volume), while Venom trades at Rp333.71 (market cap Rp340,86M, Rp2,89M 24h volume). The key difference: Injective is far larger — about 27254.6× Venom's market cap, and Venom's supply is capped (988,9M / 8B VENOM (13%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Venom for 22 Days on average.
| INJ | VENOM | |
|---|---|---|
Market Cap | Rp9,29T | Rp340,86M |
Volume (24h) | Rp1,82T | Rp2,89M |
Circulating Supply | 100M INJ | 988,9M / 8B VENOM (13%) |
Typical Hold Time | 36 Days | 22 Days |
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.
Venom (VENOM) currently holds a market capitalization of Rp340.86 million with a circulating supply of 988.9 million tokens (13% of max supply). The asset shows limited market activity with an average hold time of 22 days, indicating moderate trader retention. No recent protocol updates or significant ecosystem developments were identified during the analysis period.
Overall outlook remains cautious due to low circulation rate and limited market data. Key opportunities include potential future protocol development, while major risks involve low liquidity and the speculative nature of early-stage crypto assets. Investors should monitor for increased network adoption and exchange listings.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →Venom is a Layer 0 and Layer 1 network built on mesh technology that supports large-scale platforms like stablecoins and CBDCs. Its high scalability, speed, and low fees make it ideal for Web3 dApps, ensuring security and stability for high-load systems.
Read more on VENOM →